Biogen Inc. (BIIB) is a leading biotechnology company focused on discovering, developing, and delivering therapies for ...

Danaher is seeing strong Biotechnology growth as bioprocessing demand rises, with equipment orders up more than 30% and core ...

Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now. Just because tech and innovation took some big hits in last year’s selloff doesn ...

Making its debut on 06/23/2005, smart beta exchange traded fund Invesco Biotechnology & Genome ETF (PBE) provides investors broad exposure to the Health Care ETFs category of the market. What Are ...

First Trust NYSE Arca Biotechnology Index ETF is an exchange-traded fund that seeks to track the NYSE Arca Biotechnology Index, which consists of a cross section of small, mid and large capitalization ...

At the recent Benzinga Virtual Healthcare Summit, Laura Chico, Ph.D., senior vice president of equity research at Wedbush Equity Research, shared her optimistic views on the 2024 biotech IPO market ...

Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause ...

Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow. Try it Now Nasdaq Index Research Product Development Specialist Mark Marex joins Jill ...

This Scientific Reports Collection welcomes original research on Industrial Biotech at Scale: Processes, Products, and Performance. Narrative review articles are also welcomed, to our sister journal ...

This interactive course gives clinical affairs, regulatory and quality professionals a focused overview of EU IVDR 2017/746 performance study requirements for IVDs and companion diagnostics, with an ...